Lv3
278 积分 2025-11-22 加入
SSIEM 2015 Annual Symposium
4个月前
已完结
ENCORE: A randomized, controlled, open label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results
4个月前
已完结
A study investigating the efficacy and safety of intravenous (IV) ATB200 when Co-administrated with oral AT2221 in adult subjects with Pompe disease compared with Alglucosidase Alfa/Placebo
4个月前
已关闭
A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of Genz 112638 in Patients with Gaucher Disease Type 1 who have been Stabilized with Cerezyme
4个月前
已关闭
皖公网安备34019202002308
